There are a couple of corrections.
It's not the same company. It's a different company. The actual ratio between the price of Cystagon and the price of Procysbi is even more outrageous, I would say. It was closer to $5,000 a year for Cystagon and about $300,000 for Procysbi.
I can't really speak too much to that particular example because that drug is currently under investigation and could potentially go to a hearing. Typically, when you see an original version of a drug that has conventional release characteristics—you just swallow it and it gets absorbed by the stomach—it gets genericized with a brand name company to retain some market share. It comes out with an extended release version of that same product, which is analogous to the situation—